Matteo Bellone

Matteo Bellone is a researcher at Università degli Studi di Milano, specializing in Clinical Immunology and Cancer Immunology. He earned his MD with honors and completed a 3-year postdoctoral fellowship at the University of Minnesota under Dr. Bianca Conti-Fine, focusing on autoimmunity. His work explores the intersection of immunology, cancer treatment, and microbiome interactions.

• Board Certified: Allergology and Clinical Immunology
• Training: Autoimmunity at University of Minnesota
• Editorial Roles: Associate Editor for Cancer Immunity and Immunotherapy (Frontiers in Immunology)

Dr. Bellone's research investigates how the gut microbiota influences immunotherapy efficacy and toxicity, particularly in multiple myeloma. He examines microbial modulation of immune responses, dietary interventions, and PSMA-targeted radiopharmaceuticals for cancer imaging. His work addresses challenges in immune checkpoint blockade and adoptive cell transfer therapies.

Recent publications highlight his focus on the microbiome's role in PD-1/PD-L1 inhibition, tumor microenvironment dynamics, and microbiota-based biomarkers for plasma cell disorders. He actively contributes to preclinical radiopharmaceutical development and participates in the Italian NIBIT network for tumor biotherapy.